|
Volumn 96, Issue 4, 2013, Pages
|
Multimodality therapy for large cell neuroendocrine carcinoma of the thymus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
ETOPOSIDE;
FLUORODEOXYGLUCOSE F 18;
ADULT;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SCINTISCANNING;
CANCER SURGERY;
CARDIOPULMONARY BYPASS;
CASE REPORT;
CELL VIABILITY;
CHEMORADIOTHERAPY;
CLINICAL EFFECTIVENESS;
COMPUTER ASSISTED TOMOGRAPHY;
COUGHING;
DRUG RESPONSE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LARGE CELL NEUROENDOCRINE CARCINOMA;
MALE;
MEDIASTINUM MASS;
MULTIMODALITY CANCER THERAPY;
POSITRON EMISSION TOMOGRAPHY;
PREOPERATIVE RADIOTHERAPY;
PRIORITY JOURNAL;
RADIATION DOSE FRACTIONATION;
RADIATION RESPONSE;
THYMECTOMY;
THYMUS CANCER;
THYMUS LARGE CELL NEUROENDOCRINE CARCINOMA;
TUMOR BIOPSY;
13;
ADULT;
CARCINOMA, LARGE CELL;
CARCINOMA, NEUROENDOCRINE;
COMBINED MODALITY THERAPY;
HUMANS;
MALE;
THYMUS NEOPLASMS;
|
EID: 84885208314
PISSN: 00034975
EISSN: 15526259
Source Type: Journal
DOI: 10.1016/j.athoracsur.2013.04.107 Document Type: Article |
Times cited : (12)
|
References (8)
|